Please login to the form below
Futures Academy
This page shows the latest Futures Academy news and features for those working in and with pharma, biotech and healthcare.
GCI Health expands into Asia, Lucid adds to Futures Academy and more
I’m thrilled to have her heading our Asia-Pacific business.”. Lucid Group adds to Futures Academy. ... Lucid has welcomed six new graduates into its training programme Futures Academy, which was launched in 2017.
Latest news
-
Lucid’s first class of 2018 graduates from Lucid’s Futures Academy
Four graduates complete an eight-week training course. The Lucid Futures Academy, a graduate programme formed by medical communications company Lucid Group, has seen four of its new hires graduate after
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
A Magical Future – A year on from the graduate scheme
Emilie discusses her #LucidLife journey during the past year, after joining Lucid through their graduate scheme. The summer after I graduated from university, I spent a lot of time trying to figure out what my future would hold. I knew I wanted to
-
The Lucid Group Futures Academy welcomes its 2021 cohort
This week Lucid welcomed its newest cohort of graduates onto the 2021 Futures Academy programme. ... The Futures Academy will take them on an exciting journey, starting with a structured eight-week onboarding programme that brings the pharma and medcomms
-
Lucid Group kick starts its 2020 Futures Academy
It’s a new year and the start of a new career for the six graduates starting on Lucid’s Futures Academy this week. ... The Futures Academy begins with an eight-week intensive training course, designed for scientifically curious graduates entering the
-
Lucid Group welcomes three new graduates ahead of the 2020 Futures Academy
Three new graduates have joined the Lucid Group family ahead of the launch of the 2020 Futures Academy in January. ... The Futures Academy is an annual programme, so if you want to be part of something magical, get in touch.
-
My adventure into the world of Medcomms and Lucid’s Futures Academy
I first came across Lucid, and the Futures programme, when I met Daniel Newbury (a common denominator between the new recruits) at the University of Bristol careers fair. ... the next step of the Futures programme.
More from PMHub
Approximately 3 fully matching, plus 15 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
-
Senior Account Manager
-
Salary TBC
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Court rules on AZ and EU’s COVID-19 vaccine dispute
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- BMS’s oral AML therapy Onureg receives EU approval
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
- Breaking Down the Wall: Blockchain in Healthcare and Pharma
- Building Better Patient Advocates Through Authentic Partnerships
- Virgo Health makes two hires to leadership team
- Hanover Health appoints Aleksandra Lugović as an associate director
- GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy
- Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
- Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- Diversity and inclusion in clinical trials
- BMS’ CAR T therapy Breyanzi shows benefit in B-cell lymphoma study
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Numbers, navigation, and narratives: digital storytelling in medical communications
- Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
- Is this common data mistake killing your digital patient recruitment?
- Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
- The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
- By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
